Journals / Ankara Medical Journal / 2021 / Cilt: 21 - Sayı: 3

CLINICAL SIGNIFICANCE OF PLATELET PARAMETERS IN THE DIFFERENTIAL DIAGNOSIS OF THROMBOCYTOPENIA

TROMBOSİTOPENİNİN AYIRICI TANISINDA TROMBOSİT PARAMETRELERİNİN KLİNİK ÖNEMİ

Pages
420–427
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The present results showed that there were no statistically significant differences between the groups in terms of age, gender and PDW.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Bone Marrow (BM) examination is the gold-standard test in discriminating between hyperdestructive thrombocytopenia and hypoproductive thrombocytopenia.
📊
Key Findings & Data:Materials and Methods: One hundred sixty-four (164) patients with thrombocytopenia were included in the present study.
💡
Conclusion & Impact:The present results showed that there were no statistically significant differences between the groups in terms of age, gender and PDW.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Bone Marrow (BM) examination is the gold-standard test in discriminating between hyperdestructive thrombocytopenia and hypoproductive thrombocytopenia. However, BM examination is an invasive, time-consuming, and expensive approach. Therefore, BM study is not recommended as the first-line method. Recent studies showed that platelet parameters such as mean platelet volume (MPV), plateletcrit (PCT), platelet size deviation width (PDW) could be used for differential diagnosis of thrombocytopenia. In the present study, accordingly, we aimed to investigate the significance of these parameters in the differential diagnosis of thrombocytopenia. Materials and Methods: One hundred sixty-four (164) patients with thrombocytopenia were included in the present study. The patients were divided into two groups according to the time of the diagnosis of thrombocytopenia: hyperdestructive (75 ITP) and hypoproductive (25 AA, 25 MDS, 24 AML, 15 ALL). The diagnosis was made based on hematological, pathological, and chromosomal analyses and guidelines. Samples for complete blood counts were collected in K3EDTA tubes and analyzed with an automated hematology analyzer, Beckman-Coulter. Results: The platelet count was similar in both groups. The present results showed that there were no statistically significant differences between the groups in terms of age, gender and PDW. However, MPV was significantly higher in the hyperdestructive group than the hypoproductive group. By contrast, PCT was considerably lower in the hyperdestructive group than the hypoproductive group. Conclusion: The results of the present study indicated that these platelet parameters might provide additional contributions to strengthen the diagnosis in patients diagnosed with ITP and would be beneficial to consider the thrombocyte parameters as well as the clinical and other laboratory tests of the patient.

Özet

Objectives: Bone Marrow (BM) examination is the gold-standard test in discriminating between hyperdestructive thrombocytopenia and hypoproductive thrombocytopenia. However, BM examination is an invasive, time-consuming, and expensive approach. Therefore, BM study is not recommended as the first-line method. Recent studies showed that platelet parameters such as mean platelet volume (MPV), plateletcrit (PCT), platelet size deviation width (PDW) could be used for differential diagnosis of thrombocytopenia. In the present study, accordingly, we aimed to investigate the significance of these parameters in the differential diagnosis of thrombocytopenia. Materials and Methods: One hundred sixty-four (164) patients with thrombocytopenia were included in the present study. The patients were divided into two groups according to the time of the diagnosis of thrombocytopenia: hyperdestructive (75 ITP) and hypoproductive (25 AA, 25 MDS, 24 AML, 15 ALL). The diagnosis was made based on hematological, pathological, and chromosomal analyses and guidelines. Samples for complete blood counts were collected in K3EDTA tubes and analyzed with an automated hematology analyzer, Beckman-Coulter. Results: The platelet count was similar in both groups. The present results showed that there were no statistically significant differences between the groups in terms of age, gender and PDW. However, MPV was significantly higher in the hyperdestructive group than the hypoproductive group. By contrast, PCT was considerably lower in the hyperdestructive group than the hypoproductive group. Conclusion: The results of the present study indicated that these platelet parameters might provide additional contributions to strengthen the diagnosis in patients diagnosed with ITP and would be beneficial to consider the thrombocyte parameters as well as the clinical and other laboratory tests of the patient.

🔖

Cite This Article

KARAGÜLLE, M. (2022). CLINICAL SIGNIFICANCE OF PLATELET PARAMETERS IN THE DIFFERENTIAL DIAGNOSIS OF THROMBOCYTOPENIA. Ankara Medical Journal, Cilt: 21 - Sayı: 3, 420–427. https://ajindex.com/articles/441734

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Numbenjapon T, Mahapo N, Pornvipavee R, et al. A prospective evaluation of normal platelet volume in discriminating hyperdestructive thrombocytopenia from hypoproductive thrombocytopenia. Int J Lab Hem 2008;30:408-14 (doi: 10.1111/j.1751-553X.2007.00969.x)
  2. Levine SP. Thrombocytopenia pathophysiology and classification. In: Wintrobe’s Clinical Hematology, Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rogers GM(eds), 9th ed. William & Wilkins, Baltimore:1999;1579–82
  3. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. British Journal of Hematology 2003;120:574–96 (doi: 10.1046/j.1365- 2141.2003.04131.x)
  4. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballen PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenia purpura, a practical guideline developed by explicit methods for the American Society of Hematology. Blood, 1996; 88:3–40 (doi:10.1182/blood.V88.1.3.3)
  5. Mak YK, Yu PH, Chan CH, Chu YC. The management of isolated thrombocytopenia in Chinese adults: does bone marrow examination have a role at presentation? Clinical and Laboratory Hematology 2000; 22: 355–8 ( doi: 10.1046/j.1365-2257.2000.00340.x)
  6. Marsh JC, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, Mc Can SR, Mercieca J, Oscier D, Roques AW, Yin JA. British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquired aplastic anemia. British Journal of Hematology 2003;123:782–801(doi: 10.1046/j.1365-2141.2003.04721.x)
  7. Niethammer AG, Forman EN. Use of the platelet histogram maximum in evaluating thrombocytopenia. American Journal of Hematology 1999;60:19–23 (doi: 10.1002/(sici)1096- 8652(199901)60:1 3.0.co;2-1
  8. Kaito K, Otsubo H, Usui N, Yoshida M. Platelet size deviation width, platelet large cell ratio and mean platelet volume have sufficient sensitivity and specifity in the diagnosis of immune Thrombocytopenia. British Journal of Hematology 2005;128(5):698–702 (doi:10.1111/j.1365- 2141.2004.05357.x)
  9. Rajantie J, Javela K, Joutsi-Korhonen L, Kekomaki R. Chronic thrombocytopenia of childhood: use of non-invasive methods in clinical evaluation. European Journal of Hematology 2004;72:268–72 (doi: 10.1111/j.1600-0609.2004.00215.x
  10. Ihtesham MK, Ullah I. Diagnostic importance